These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 39125890)

  • 1. Phage Therapy: An Alternative Approach to Combating Multidrug-Resistant Bacterial Infections in Cystic Fibrosis.
    Cocorullo M; Stelitano G; Chiarelli LR
    Int J Mol Sci; 2024 Jul; 25(15):. PubMed ID: 39125890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in Phage Therapy: Targeting the
    Lauman P; Dennis JJ
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Alipour-Khezri E; Skurnik M; Zarrini G
    Viruses; 2024 Jun; 16(7):. PubMed ID: 39066214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutralizing antibodies after nebulized phage therapy in cystic fibrosis patients.
    Bernabéu-Gimeno M; Pardo-Freire M; Chan BK; Turner PE; Gil-Brusola A; Pérez-Tarazona S; Carrasco-Hernández L; Quintana-Gallego E; Domingo-Calap P
    Med; 2024 Sep; 5(9):1096-1111.e6. PubMed ID: 38917792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
    Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phage therapy as strategy to face post-antibiotic era: a guide to beginners and experts.
    Royer S; Morais AP; da Fonseca Batistão DW
    Arch Microbiol; 2021 May; 203(4):1271-1279. PubMed ID: 33474609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial resistance: use of phage therapy in the management of resistant infections.
    Ikpe F; Williams T; Orok E; Ikpe A
    Mol Biol Rep; 2024 Aug; 51(1):925. PubMed ID: 39167154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phage therapy: an alternative treatment modality for MDR bacterial infections.
    Pal N; Sharma P; Kumawat M; Singh S; Verma V; Tiwari RR; Sarma DK; Nagpal R; Kumar M
    Infect Dis (Lond); 2024 Oct; 56(10):785-817. PubMed ID: 39017931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacteria-eating viruses could provide a route to stability in cystic fibrosis.
    Svoboda E
    Nature; 2020 Jul; 583(7818):S8-S9. PubMed ID: 32728257
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolutionary Rationale for Phages as Complements of Antibiotics.
    Torres-Barceló C; Hochberg ME
    Trends Microbiol; 2016 Apr; 24(4):249-256. PubMed ID: 26786863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current status of phage therapy and its advancement towards establishing standard antimicrobials for combating multi drug-resistant bacterial pathogens.
    Ali Y; Inusa I; Sanghvi G; Mandaliya VB; Bishoyi AK
    Microb Pathog; 2023 Aug; 181():106199. PubMed ID: 37336428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis.
    Conway SP; Brownlee KG; Denton M; Peckham DG
    Am J Respir Med; 2003; 2(4):321-32. PubMed ID: 14719998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimizing bacteriophage treatment of resistant
    Ulrich L; Steiner LX; Giez C; Lachnit T
    mSphere; 2024 Jul; 9(7):e0070723. PubMed ID: 38934592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zebrafish as an effective model for evaluating phage therapy in bacterial infections: a promising strategy against human pathogens.
    Plumet L; Costechareyre D; Lavigne J-P; Kissa K; Molle V
    Antimicrob Agents Chemother; 2024 Oct; 68(10):e0082924. PubMed ID: 39248472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phage Therapy Application to Counteract Pseudomonas aeruginosa Infection in Cystic Fibrosis Zebrafish Embryos.
    Cafora M; Forti F; Briani F; Ghisotti D; Pistocchi A
    J Vis Exp; 2020 May; (159):. PubMed ID: 32478753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways.
    Trend S; Fonceca AM; Ditcham WG; Kicic A; Cf A
    J Cyst Fibros; 2017 Nov; 16(6):663-670. PubMed ID: 28720345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phage Milagro: a platform for engineering a broad host range virulent phage for
    Yao G; Le T; Korn AM; Peterson HN; Liu M; Gonzalez CF; Gill JJ
    J Virol; 2023 Nov; 97(11):e0085023. PubMed ID: 37943040
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bacteriophages in the battle against multidrug resistant bacteria].
    van der Meer JWM; Vandenbroucke-Grauls CMJE
    Ned Tijdschr Geneeskd; 2018; 162():D2433. PubMed ID: 29600928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.